← Leaderboards
Gregory C Ippolito
University Of Texas Austin
$1,485,811
Attributed
$1,682,154
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $815.9K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,682,154 · 4
By mechanism
U54$1,133,499 · 2
R56$392,687 · 1
F32$155,968 · 1
Top collaborators
- S Louis Bridges1 shared
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesProteinsSerumResponseMolecularB-LymphocytesSourceImmunoglobulin GMonoclonal AntibodiesIn VivoEpitopesEpitope MappingExperimental StudyPatternAreaCross ReactivityAntibody ResponseBaseImmunoglobulin ABindingCloningCohortClinical TrialsAdvisory Committees
Grant awards (7)
Core C: Immunoglobulin Proteomics in COVID-19$136,800
U54 · FY2024 · CA · contact PI
Core C: Immunoglobulin Proteomics in COVID-19$180,753
U54 · FY2022 · CA · contact PI
Core C: Immunoglobulin Proteomics in COVID-19$815,946
U54 · FY2020 · CA · contact PI
Molecular, Functional and Structural Analyses of Anti-PAD Antibodies in Rheumatoid Arthritis$392,687
R56 · FY2019 · AI
BCL11A in normal B-cell biology and malignancy$53,992
F32 · FY2007 · CA · contact PI
BCL11A in normal B-cell biology and malignancy$52,048
F32 · FY2006 · CA · contact PI
BCL11A in normal B-cell biology and malignancy$49,928
F32 · FY2005 · CA